Medical Updates

Management of Infection in Ventilator-associated Pneumonia with Injected Colistin and Nebulized Tobramycin

Injected colistin plus nebulized tobramycin seemed to be a good alternative treatment for the management of infection in ventilator-associated...

30 Dec, 2019

 
Email this page
Body Temperature at Admission Independently Predicts the Risk of Mortality in Critically Ill Patients

Body temperature (BT) at admission is a highly significant and independent risk predictor for both overall intra-intensive care unit (ICU) and long-...

19 Dec, 2019

 
Email this page
qSOFA and SOFA Scores Might be Clinically Valuable Markers of Severe Malaria Presenting as Sepsis

A recent prospective study demonstrated that quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) and SOFA score could be potential...

17 Oct, 2019

 
Email this page
Flucytosine Combined with Amphotericin B, Voriconazole or Micafungin Might Be Beneficial in Treatment of Candida auris Infections

The current study evaluated the in vitro interaction between flucytosine and with a polyene (amphotericin B), an echinocandin (micafungin) or an...

16 Oct, 2019

 
Email this page

eCMEs

Date: 21st Jan 2020
Time:
Date: 21st Jan 2020
Time:
Date: 21st Jan 2020
Time:

Key Trials

Indian Prospective Study Comparing the Nephrotoxicity of Colistin and Polymyxin B Administered in Currently Recommended Doses

Polymyxins have been associated with a risk of nephrotoxicity. Different studies have evaluated the toxicity of polymyxins and have demonstrated a...

GLIMP Study: Worldwide Prevalence and Risk Factors for MRSA Pneumonia

The Global Initiative for MRSA Pneumonia (GLIMP) study, is an international, multicenter study aimed to determine the point prevalence and specific...

BLISS Study: Continuous Administration of Beta-lactams Associated with Higher Clinical Cure Rates and Better PK/PD Target Attainment Compared to Intermittent Bolus Dosing

Beta-lactam Infusion in Severe Sepsis (BLISS) study is a prospective, two-centre, open labelled, randomized controlled trial of continuous infusion...

ZEPHyR Study: Linezolid Superior to Vancomycin in Treatment of MRSA Nosocomial Pneumonia

ZEPHyR (linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) is a...

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

MRSA: The Clinician’s Challenge

The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.

Phosome IV (Liposomal Amphotericin B) Monograph

Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...

Liposome: The Magic Bullet

This article briefs out the structural aspects, advantages and application of liposomes and elaborates on liposomal amphotericin B as an antifungal...

Infographics

Explore >>

Currently there is no content under this category.

Poll

Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
29% (2 votes)
Sometimes
29% (2 votes)
No
43% (3 votes)
Total votes: 7